Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

09/11/2016 ​Barcelona, a Bright Spot in the European Digital Landscape 02/11/2016 ​Malaysia Comes to Discover the Barcelona DC Cluster Initiative Set Up In Barcelona Synchrotron Park 26/10/2016 ​MIRAS New ALBA Synchrotron Beamline Goes Under Researchers Skin 19/10/2016 Christian Ketels: “Thanks to clusters, Catalonia is much more attractive to foreign companies” 11/10/2016 ​Barcelona DC Cluster Initiative 06/10/2016 ​Barcelona Synchrotron Park Sponsors the Fifth Ideas Generation Program
21 22 23 24 25 26 27 28 29 30 31